Penn's ImmunoRevolution began over 20 years ago. At the time, there were limited funding opportunities for novel ideas and researchers relied on philanthropy to fuel innovation.
Now, the breakthrough has arrived. But we still need more partners – more revolutionaries – to join the fight, so Penn's Abramson Cancer Center can design more treatments that put more patients' cancer into remission.
Our work makes a difference not just to science, but to the future of all of us. Its full potential is nothing short of revolutionary.